Solventum said it increased the Aggregate Cap for its cash tender offers for notes on September 8, 2025 from $1.75 billion to $2 billion. The company raised the Pool 1 Maximum Amount from $1.25 billion to $1.5 billion and the Tender SubCap from $500 million to $650 million.

1. 01

   Solventum said it increased the Aggregate Cap for its cash tender offers for notes on September 8, 2025 from $1.75 billion to $2 billion. The company raised the Pool 1 Maximum Amount from $1.25 billion to $1.5 billion and the Tender SubCap from $500 million to $650 million.

2. 02

   Solventum said it expects to accept for purchase on a prorated basis notes maturing in 2027, 2029 and 2054 (5.450%, 5.400% and 5.900%), and does not expect to accept for purchase notes of 5.600% due 2034 and 5.450% due 2031. The company added it does not expect to accept for purchase any notes tendered after the Early Tender Date.

3. 03

   Solventum said the Financing Condition, which refers to receipt and repatriation of proceeds from the sale of its purification and filtration business, excluding the drinking water filtration business, to Thermo Fisher Scientific Inc., has been satisfied as of the date of the press release. The company said settlement is expected on September 10, 2025, and holders of accepted notes will receive accrued and unpaid interest.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call. Some paragraphs were omitted because their support in the source could not be confirmed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.